The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
| Date first appeared online | 15/09/2014 |
| DOI | 10.1128/AAC.03707-14 |
| Authors | Warrilow A., Parker J., Kelly D., Kelly S., Hull C. |
| Journal Name | Antimicrobial Agents and Chemotherapy |
| Volume | 58 |